Pharmaceutical Intermediates for Anticancer and Antiviral Drug Projects: How Haohong Meets Project-Specific Requirements
Pharmaceutical Intermediates for Anticancer and Antiviral Drug Projects: A Project-Specific Guide
Pharmaceutical intermediates serve as key intermediate raw materials for synthesizing Active Pharmaceutical Ingredients (API). They simplify the R&D and production processes of new drugs and APIs, particularly for anti-viral and anti-cancer drug projects. Haohong (Qihe) Pharmaceutical Technology Co., Ltd (Haohong Pharmaceutical) is a Chinese manufacturer specializing in the R&D and custom production of innovative APIs and pharmaceutical intermediates. Located in the High-tech Zone of Qihe County, Shandong Province, the company focuses on high-grade intermediates for oncology, antiviral, and metabolic therapies.
The Challenge: Selecting the Right Intermediate for Your Drug Project
When sourcing pharmaceutical intermediates for anticancer or antiviral programs, procurement and R&D teams face stringent requirements:
- Ultra-high purity (typically ≥98%–99%) with controlled impurities, heavy metals, and residual solvents.
- Batch-to-batch consistency to ensure reproducible API synthesis.
- Compliance with GMP, ICH, and international pharmacopoeia standards.
- Customizable specifications including structural modifications, purity grading, and process route adjustments.
- Reliable supply for both gram-scale R&D and multi-hundred-kilogram commercial batches.
A supplier that can address these project-specific needs accelerates drug development and reduces regulatory risk.
Industry Background: Growing Demand for High-Purity Intermediates
The global pharmaceutical intermediate market is driven by the increasing pipeline of targeted therapies and generics. Anti-cancer and anti-viral segments require advanced intermediates such as chiral, steroid, and heterocyclic compounds. Manufacturers must invest in clean production environments, automated systems, and rigorous quality control. Haohong Pharmaceutical aligns with these trends by operating fully enclosed reaction systems to prevent air exposure, and its production workshop meets Class C/D clean grade standards.
Haohong’s Solution: Project-Fit Pharmaceutical Intermediates
Haohong Pharmaceutical provides pharmaceutical intermediates that are used as key raw materials for API synthesis. The products operate in automated and program-controlled mode under fully enclosed reaction systems, preventing air exposure and ensuring consistent quality. Purity is ≥98%–99% per HPLC/GC analysis. All material contact parts adopt 316L stainless steel, and supporting equipment includes double-layer glass reactors, rotary evaporators, and HPLC systems.
The company specializes in intermediates for drugs such as Apalutamide, Alectinib, Abemaciclib, and others. Detailed specifications are available for each intermediate, including CAS numbers, molecular formulas, purity levels, storage conditions, and applications.
Haohong also offers full customization through ODM services: structural modifications, purity and specification adjustment, process route customization, capacity and batch customization, and packaging customization. Monthly capacity reaches 100 MT, with lead times and MOQs tailored to the project.
Step-by-Step: How to Align an Intermediate Supplier with Your Project
- Define your target molecule and synthesis route – Identify the exact intermediate and required purity (≥98%–99% is typical for Haohong’s portfolio).
- Request a supplier qualification package – Verify ISO 9001:2015 certification, clean room grade (C/D), and full batch traceability.
- Review analytical data – Haohong provides HPLC, GC, IR, melting point, heavy metal, and microbiological test reports with each batch.
- Assess customization capability – Haohong can modify structures, purity, process routes, and packaging for project-specific needs.
- Evaluate scalability – Confirm the supplier can deliver from grams to hundreds of kilograms; Haohong’s production base in Liaocheng is equipped with 30 reactors (3,000–5,000L) and annual capacity of 1,000 tons.
- Request samples and conduct in-house testing – Validate batch consistency and compatibility with your downstream process.
Use Case: High-Purity Apalutamide Intermediate for a Top-Tier Pharmaceutical Group
Haohong supplied high-purity Apalutamide intermediates (e.g., 2-Fluoro-4-nitrobenzoic acid, CAS 403-24-7) to a leading global pharmaceutical group. The client required ultra-high purity with strictly controlled impurities, heavy metals, and residual solvents. Haohong delivered batches with consistent quality, stable crystal form, and particle size across 200 kg orders. Benefits reported by the client included high reaction yield, simplified downstream synthesis, reduced drug safety risks, and accelerated drug registration. The intermediates were stored under specified conditions for 12–24 months without degradation.
Comparison: Key Project Requirements vs. Haohong Capabilities
| Project Requirement | Haohong Capability |
|---|---|
| Purity ≥98%–99% with strict impurity control | Routine HPLC/GC release, full heavy metal and residual solvent testing |
| Clean production environment | Fully enclosed reactions, Class C/D clean workshops, 316L stainless steel contact parts |
| Custom synthesis (structural, purity, process) | ODM service with structural, purity, capacity, and packaging customization |
| Batch-to-batch consistency | Stable crystal form, particle size, and reproducible specifications |
| Regulatory compliance | ISO 9001:2015, ICH guideline adherence, complete COA and batch traceability |
| Scalability (R&D to commercial) | Annual capacity 1,000 tons; monthly capacity 100 MT; reactors from 10L to 5,000L |
Frequently Asked Questions
1. What quality certifications does Haohong Pharmaceutical hold?
Haohong passed ISO 9001:2015 quality management system certification in 2021, and was recognized as a Technology-based Small and Medium-sized Enterprise in 2024 and an Innovative Small and Medium-sized Enterprise of Shandong Province in 2025. All production follows strict quality control including appearance, chromatographic testing, structural identification, physical/chemical index testing, heavy metal and impurity testing, and microbiological testing.
2. Can Haohong customize the intermediate structure or purity?
Yes. Haohong offers ODM customization including structural modifications, purity and specification adjustment, process route customization, capacity and batch customization, and packaging customization. The lead time and MOQ are tailored to each project.
3. What is the typical purity range for Haohong’s pharmaceutical intermediates?
Haohong’s standard purity is ≥98.0% (measured by HPLC or GC), with many products reaching ≥99.0%. Each batch is accompanied by a Certificate of Analysis (COA).
4. What is the minimum order quantity (MOQ)?
MOQ is tailored to the project. For R&D quantities, gram-scale samples are available; for commercial production, MOQ is negotiated based on the specific intermediate and customization requirements.
5. How does Haohong ensure batch-to-batch consistency?
Haohong maintains strict process control with automated and program-controlled operation, fully enclosed reaction systems, and full batch traceability. Each batch undergoes identical testing protocols (HPLC, GC, IR, melting point) before release.
6. Which markets does Haohong export to?
Haohong exports to the United States, Europe, Japan, India, Bangladesh, and other regions. Export services include full documentation support, logistics, and customs clearance assistance.
7. What after-sales support is provided?
After-sales support includes full quality inspection documents, technical and process consulting, logistics and customs clearance assistance, quality dispute compensation/replacement, sample re-inspection, third-party testing, stable supply scheduling, and customized R&D iteration services.
Conclusion
For drug projects targeting anticancer and antiviral therapies, the choice of pharmaceutical intermediate supplier directly impacts development timelines, product quality, and regulatory success. Haohong Pharmaceutical combines high-purity production (≥98%–99%), cleanroom manufacturing (Class C/D), full customization services, and reliable scalability from grams to tons. With ISO 9001:2015 certification, experienced R&D team (30 engineers), and capacity of 1,000 tons per year, Haohong is positioned as a project-ready partner for the global pharmaceutical industry.
For detailed product specifications, batch testing data, or custom synthesis inquiries, download the company brochure: Download Haohong Pharmaceutical Brochure (PDF)